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We can train them, but how can we  
retain them?
To the Editor: The Department of Surgery at the Nelson R 
Mandela School of Medicine is proud of its 100% pass rate 
in the October 2008 Colleges of Medicine of South Africa 
examinations held in Durban. Most candidates attended the 
graduation and joined the 3 who passed in May as registered 
specialists in general surgery. This represents a stalwart effort 
on the part of the candidates and their tutors, the consultants 
in the department. Professor Robbs, in his retirement year, 
was justly proud of this achievement  and honoured that our 
candidates asked him to robe them at the graduation ceremony. 
Despite the quality and success of the trainees, only 3 of 
the 15 have been appointed as consultants in KwaZulu-Natal 
province, one has left for Witbank, and one is about to leave 
to take up an appointment in Johannesburg – this despite the 
fact that the departments of surgery in the province have the 
posts to employ the majority of them. Unfortunately, although 
a total of 9 posts are available and have been motivated to 
be financially unfrozen, no interviews have taken place. This 
inertia at the provincial administrative level to finance and 
advertise these posts exists despite a public statement to 
the contrary. The Medical School has also been ineffectual 
in influencing the provincial health authorities to fund over 
one-third of these posts which are on the ‘joint medical 
establishment’, i.e. joint university and provincial posts. 
This impasse surely needs to be addressed so that 
interventions to institute meaningful dialogues between the 
province and the Medical School can occur.
If no urgent solution to this problem is found these 
individuals will leave, and at least 3 are actively pursuing an 
overseas option. Others will head for the already over-manned 
private sector or to other provinces. Once they leave they are 
unlikely to return.
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The tokoloshe homunculus
To the Editor: The hippocampus is that part of the limbic 
system responsible for short-term and spatial memory. 
Increased activation of the hippocampus and related structures 
during seizures and REM sleep has been demonstrated in 
functional MRI (fMRI) studies. In fact, the hippocampus is 
particularly susceptible to electrical overstimulation and 
seizure sequelae. The dorsal extension of the hippocampus 
(the indusium griseum – also called the supracallosal gyrus) 
comprises two thin grey-matter strips that overlay the corpus 
callosum; it is a vestigial structure of unknown function in the 
postnatal brain.
A popular theory in neuroscience literature, proposed 
first by David Chamberlain1 and later by Michael Persinger,2 
is that the indusium griseum plays a functional role in the 
developing fetus; it is viewed primarily as the embryonic 
equivalent of the adult hippocampus and secondarily as the 
sensory homunculus of the fetus. In the latter function, it has 
a somatotopic representation of the fetus equivalent to the 
adult postcentral gyrus representation of the adult form. This 
fact implies that stimulation of this vestigial structure could 
conceivably result in the visual or otherwise experience of the 
stored sensory homunculus of the fetus. The outcome would 
be visual hallucinations of a small humanoid with a large head, 
big eyes and a small body.
Various descriptions of visitations by tokoloshe-like small 
humanoids have been documented over the centuries; they are 
named differently by different cultures, e.g. cherubs, harpies, 
muses, incubi, succubi – and perhaps even Martians. Temporal 
lobe epileptics are known to have formed hallucinations 
that include a human form of varying sizes. It is likely that 
activation of the indusium griseum secondary to hippocampal 
stimulation, by moments of distress, dreaming or seizures, can 
result in a visual experience of small humanoid creatures of 
this type.
The tokoloshe (or tikoloshe or tikoloshi) in African 
mythology is a humanoid creature about 1 m tall, with a large 
head, big eyes and a slender torso. It is (allegedly) mostly 
nocturnal and friendly to children but can be harmful to adults 
if under the influence of evil witches. Raising one’s bed by 
placing it on bricks (allegedly) offers some protection against 
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the tokoloshe (which is also now allegedly responsible for 
spreading HIV infection).3
It has often been argued that the search for answers to age-
old conundrums cannot always be found in scientific study. 
Beliefs are just what they are and should be left alone. But 
this instance does beg the question: Could the tokoloshe be 
the experience of a stimulated indusium griseum? And do we 
here in Africa have a pre-programmed tokoloshe homunculus 
waiting to be activated in times of distress, dreamlike states 
or during a seizure? And lastly, but most challengingly, can a 
tokoloshe homunculus be imaged by fMRI during an episode?
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HRT prescriptions linked to 25% of 
breast cancers in California
To the Editor: I am a breast radiologist, running a 
multidisciplinary breast care centre together with two surgeons 
and a practitioner in oncology. We add about 90 - 100 new 
cancer cases to our files annually.
I am amazed to see how we doctors persist in our old ways 
of prescribing medicine and how reluctant we are to change, 
despite recent data. Our medical history is flawed with 
mistakes that sometimes took hundreds of years to correct 
(400 years to admit that vitamin C prevents scurvy, decades to 
admit that Semmelweis was right in washing hands and that 
bloodletting had no benefit). It took the USA’s Food and Drug 
Administration (FDA) 37 years to ban diethylstilbestrol, after 
the first synthetic oestrogen caused vaginal cancer in female 
babies.
Despite many colleagues criticising the composition of 
the Women’s Health Initiative (WHI) study1 on hormones, 
it nevertheless had a major impact on breast cancer figures. 
Women became scared, stopped their prescriptions, and then 
… breast cancer figures tumbled – for the first time in 30 years2 
– and in the 1970s also dropped after the scare of oestrogen 
causing endometrial cancer.3
The Stanford University Group could find no other cause of 
the unprecedented drop – other than women stopping their 
HRT prescriptions.4,5 A calculation by Donald A Berry, Cancer 
Research Professor of Biostatistics, Anderson Cancer Center, 
shocked us: that 25% of breast cancers in California before 2002 
could have been caused by HRT prescriptions.6 Which means 
that we, well-meaning doctors, caused cancer in our patients. 
This was 67 years after Dr Charles Dodds (inventor of the first 
synthetic oestrogen, diethylstilbestrol) and Dr Boris Shimkin 
warned that it caused cancer in their laboratory rats and that 
we did not know what the long-term effect might be on the 
human female!7
It is high time that our patients be informed about the side-
effects of prescription drugs and encouraged to make their 
own decisions, irrespective of whether the drug is thalidomide, 
Vioxx or HRT. After all, hormones are misused in a non-disease 
state like the menopause. How long will it take us to discard 
the financial gains, to admit that we are harming many of our 
patients, and to start changing our prescription habits?
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Medical aid double standards
To the Editor: I am distressed by obvious discrepancies in 
clinical standards applied by medical aids.
A friend, due for delivery of her first baby, was under the 
care of a midwife. When she went into labour, the midwife 
was unable to find her a bed at the birthing unit because all the 
beds were occupied by women who had had elective caesarean 
sections (CS). Eventually she laboured and delivered in a 
suboptimal side-room, with poor facilities for monitoring and 
delivery. She was then moved into a regular room, but she was 
told that she could only use it until the morning of the next 
day because it had been booked for another woman having an 
elective CS.
There are only a few institutions to which a midwife can 
directly admit women, and seemingly these few places are 
oversubscribed by largely unnecessary cases.
Elective CSs at maternal request are more costly, with longer 
recovery periods than elective vaginal delivery, with no clear 
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